Related Experiment Video
Updated: Oct 14, 2025

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Fluoroquinolone antibiotics and adverse events
Diva Baggio1,2,3,4, Michelle R Ananda-Rajah1,2,3,4
1Malignant Haematology and Stem Cell Transplantation Service, Alfred Health.
Abstract:
Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects. These include tendinopathy and tendon rupture, peripheral neuropathy and aortic aneurysm. Safe prescribing of fluroquinolones requires recognition of patients with risk factors for toxicity. Prompt drug discontinuation is recommended in the event of an adverse reaction. Practising antimicrobial stewardship by prescribing fluoroquinolones only when alternative drugs are unavailable is also key to limiting adverse events and antibiotic resistance.
Insights
Fluoroquinolones, effective antibiotics, carry risks like tendon rupture and neuropathy. Prescribing them cautiously and only when necessary is crucial for patient safety and combating antibiotic resistance.
Area of Science:
- Pharmacology and Infectious Diseases
Background:
- Fluoroquinolones are broad-spectrum antibiotics with excellent oral absorption.
- Their use is widespread but subject to prescribing restrictions due to potential adverse events.
Purpose of the Study:
- To highlight the risks associated with fluoroquinolone use.
- To emphasize the importance of safe prescribing practices and antimicrobial stewardship.
Main Methods:
- Review of epidemiological studies on fluoroquinolone adverse effects.
- Analysis of risk factors and management strategies for fluoroquinolone toxicity.
Main Results:
- Epidemiological data indicate an increased risk of rare but serious adverse effects.
- These include tendinopathy, tendon rupture, peripheral neuropathy, and aortic aneurysm.
- Identification of patient risk factors for toxicity is essential.
Conclusions:
- Safe fluoroquinolone prescribing necessitates recognizing at-risk patients and prompt discontinuation upon adverse reactions.
- Antimicrobial stewardship, including reserving fluoroquinolones for situations where alternatives are unsuitable, is vital to minimize harm and resistance.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

